Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2023 | The importance of monitoring genetic predispositions to bone marrow failure syndromes

Jean Soulier • 4 May 2023
MDS 2023
Anemias Fanconi Anemia Myelodysplastic Syndromes Rare Diseases

Jean Soulier, MD, PhD, Saint-Louis Hospital, Paris, France, comments on genetic predispositions to bone marrow failure syndromes, drawing focus on Fanconi anemia (FA), and highlighting the importance of monitoring these mutations regularly. This interview took place at the 17th International Congress on Myelodysplastic Syndromes 2023 (MDS 2023) held in Marseille, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Scientific Advisor for STRM.BIO

More from Jean Soulier

4:58
Pathophysiology of progression of Fanconi anemia to MDS/AML
Jean Soulier • 4 May 2023

Related Videos

2:22
Haplo-SCT for older patients with AML/MDS, and should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024
2:31
Emerging treatment options for patients with ESA-refractory MDS: luspatercept & imetelstat
Eva Hellström-Lindberg • 11 Apr 2024
1:49
The unmet needs of patients with VEXAS syndrome
Maël Heiblig • 17 Apr 2024
1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals